Axios @axios
AstraZeneca's CEO told investors that the company's coronavirus vaccine trial participant who experienced an adverse reaction had serious neurological symptoms consistent with a rare spinal disorder. https://t.co/4VKj6bdnYD — PolitiTweet.org